413 related articles for article (PubMed ID: 22951238)
1. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.
Flockhart DA
J Clin Psychiatry; 2012; 73 Suppl 1():17-24. PubMed ID: 22951238
[TBL] [Abstract][Full Text] [Related]
2. The transdermal delivery system of monoamine oxidase inhibitors.
VanDenBerg CM
J Clin Psychiatry; 2012; 73 Suppl 1():25-30. PubMed ID: 22951239
[TBL] [Abstract][Full Text] [Related]
3. The use of monoamine oxidase inhibitors in primary care.
Culpepper L
J Clin Psychiatry; 2012; 73 Suppl 1():37-41. PubMed ID: 22951241
[TBL] [Abstract][Full Text] [Related]
4. The role of monoamine oxidase inhibitors in depression treatment guidelines.
Thase ME
J Clin Psychiatry; 2012; 73 Suppl 1():10-6. PubMed ID: 22951237
[TBL] [Abstract][Full Text] [Related]
5. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art.
Rapaport MH
J Clin Psychiatry; 2007; 68 Suppl 8():42-6. PubMed ID: 17640157
[TBL] [Abstract][Full Text] [Related]
6. MAOIs and transdermal delivery.
Vandenberg CM
J Clin Psychiatry; 2012 Sep; 73(9):e28. PubMed ID: 23059160
[TBL] [Abstract][Full Text] [Related]
7. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.
Shulman KI; Fischer HD; Herrmann N; Huo CY; Anderson GM; Rochon PA
J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903
[TBL] [Abstract][Full Text] [Related]
8. Discussion: a fresh look at monoamine oxidase inhibitors for depression.
Cohen LJ; Sclar DA; Culpepper L; Flockhart DA; Hirschfeld RM; Thase ME; VanDenBerg CM
J Clin Psychiatry; 2012; 73 Suppl 1():42-5. PubMed ID: 22951242
[No Abstract] [Full Text] [Related]
9. Tyramine and new monoamine oxidase inhibitor drugs.
Simpson GM; de Leon J
Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
[TBL] [Abstract][Full Text] [Related]
10. Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants.
Stahl SM; Felker A
CNS Spectr; 2008 Oct; 13(10):855-70. PubMed ID: 18955941
[TBL] [Abstract][Full Text] [Related]
11. MAOIs: issues in treatment adherence and rates of treatment failure.
Cohen LJ; Sclar DA
J Clin Psychiatry; 2013 Jan; 74(1):e02. PubMed ID: 23419230
[TBL] [Abstract][Full Text] [Related]
12. MAOIs and depression treatment guidelines.
Thase ME
J Clin Psychiatry; 2012 Jul; 73(7):e24. PubMed ID: 22901357
[TBL] [Abstract][Full Text] [Related]
13. Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure.
Cohen LJ; Sclar DA
J Clin Psychiatry; 2012; 73 Suppl 1():31-6. PubMed ID: 22951240
[TBL] [Abstract][Full Text] [Related]
14. Revisiting monoamine oxidase inhibitors.
Krishnan KR
J Clin Psychiatry; 2007; 68 Suppl 8():35-41. PubMed ID: 17640156
[TBL] [Abstract][Full Text] [Related]
15. Current place of monoamine oxidase inhibitors in the treatment of depression.
Shulman KI; Herrmann N; Walker SE
CNS Drugs; 2013 Oct; 27(10):789-97. PubMed ID: 23934742
[TBL] [Abstract][Full Text] [Related]
16. What is the bottom line for dietary guidelines when taking monoamine oxidase inhibitors?
Marcason W
J Am Diet Assoc; 2005 Jan; 105(1):163. PubMed ID: 15635366
[No Abstract] [Full Text] [Related]
17. Monoamine oxidase-inhibiting antidepressants. A clinical update.
Murphy DL; Sunderland T; Cohen RM
Psychiatr Clin North Am; 1984 Sep; 7(3):549-62. PubMed ID: 6384960
[TBL] [Abstract][Full Text] [Related]
18. Introduction: a fresh look at monoamine oxidase inhibitors for depression.
Cohen LJ; Sclar DA
J Clin Psychiatry; 2012; 73 Suppl 1():3-4. PubMed ID: 22951235
[No Abstract] [Full Text] [Related]
19. Tyramine and irreversible monoamine oxidase inhibitors in clinical practice.
Cooper AJ
Br J Psychiatry Suppl; 1989 Oct; (6):38-45. PubMed ID: 2695126
[TBL] [Abstract][Full Text] [Related]
20. [Rational use of antidepressants in general medicine].
Verbanck P; Cnockaert P
Rev Med Brux; 1996 Sep; 17(4):224-9. PubMed ID: 8927850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
